Latest antivirals News

WHO to begin development of parallel recommendation and regulatory pathways; shortening the time taken for people to access health products
Three NYU Studies Vie for This Year’s Top Health Discovery
Cow has potential as therapeutic research model
Protecting older people in festive season
Should we still be using RATs to test for COVID? 4 key questions answered
Contagious omicron strain replicates early in infection
What you need to know about COVID, flu and RSV vaccines
Universal siRNA Covid treatment shows promise in lab
Total recall on HIV
Griffith University and Gene Company partner to create exciting RNA-based COVID anti-viral
City of Ballarat extends free Rapid Antigen Test scheme
Review of 2022 Covid winter surge package
Free Rapid Antigen Tests still available
Improving access to novel COVID-19 treatments
Estimating pandemic product needs and allocation levels
Here’s who decides cause of death, how death certificates work – and whether a person died with or of COVID
Free Covid Rapid Antigen Tests available to all Ballarat residents
More Free RATS Now Available Through Your Local Council
Omicron subvariant XBB.1.5 detected in New Zealand
Free Rapid Antigen Tests For Victorians
Aotearoa New Zealand supports Tokelau response to COVID-19
Could ‘test often, treat early’ approach help eliminate hepatitis C among people with HIV?
Assessing, Mitigating Risk in New COVID Phase: How?
Chief Health Officer Update 11 November
Chief Health Officer Update 4 November
Chief Health Officer Update 28 October
World Health Organization response to External Evaluation of Access to Covid Tools Accelerator
What AMA Securing Telehealth for COVID Patients means to you
RACGP welcomes Covid oral antiviral decision
11,500+ frontline health workers to receive $2,000 payment
Chief Health Officer Update 14 October
Chief Health Officer Update 30 September
World leaders’ UNGA pledge to vaccinate world falls woefully short as only third of countries meet target
Catholic Health Australia welcomes federal government’s extra Covid health funding
Strengthening Australia’s Covid response
First report on Australia’s pandemic preparedness
CSIRO charts our preparedness for next pandemic
RACGP: Pharmacy Guild’s antiviral misinformation cause for concern
Covid antivirals must be made available from community pharmacies
Covid Antivirals Telehealth & Resources
RACGP: Pharmacy antiviral push recipe for disaster
New Zealand to stay at Orange as winter continues
Burnet research honoured at AIDS 2022
Why do some people who take Paxlovid for COVID get ‘rebound’ symptoms?
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
RACGP releases Covid antivirals resource
Chief Medical Officer’s statement declaring monkeypox Communicable Disease Incident of National Significance
Pandemic Support Welcome